NasdaqGS:SHCLife Sciences
Sotera Health (SHC): Reassessing Valuation After Major Secondary Share Sale and Earnings Beat
Sotera Health (SHC) just navigated a complicated one two punch as affiliates of Warburg Pincus and GTCR unloaded 30 million shares in a secondary offering while the company simultaneously delivered earnings that topped Wall Street expectations.
See our latest analysis for Sotera Health.
At around $16.90, Sotera Health’s solid quarterly beat and heavy secondary selling come after a strong run. Its year to date share price return of 24.08 percent and three year total shareholder return of 96.74...